-
Giffen releases STD-prevention app
NEW YORK — A new app allows people to share their STD statuses with potential partners.
Giffen Solutions announced the launch of MedXSafe, a new feature to its MedXCom Patient platform. The app allows people to bump phones with a potential partner and exchange contact information as well as their STD status. Giffen emphasized that users choose to share their information and that the app doesn't violate medical confidentiality laws, and only licensed healthcare providers can register to use the MedXCom system.
-
FDA approves Uceris for ulcerative colitis
SAN DIEGO — The Food and Drug Administration has approved an ulcerative colitis drug made by Santarus, the drug maker said.
Santarus announced the approval of Uceris (budesonide) extended-release tablets for mild to active UC. The company plans to launch the drug in March.